Mr. Oram has more than 30 years of experience in healthcare and biotechnology companies. He has previously served as president of Orthologic and executive vice president of the Musculoskeletal Transplant Foundation.
Bone Biologics is developing a proprietary protein for use in bone regenerative medicine using the patented recombinant human protein known as UCB-1.
More articles on devices:
North American spine surgery market in 5 years: 8 things to know
Can ozone gas fix leg pain from disc herniation? 5 quick facts Triojection System’s first try
The Asia Pacific’s rising importance for the total joint market: 8 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
